SCHEMBL19341968

SCHEMBL19341968

CC(C)(C)OC(=O)N1CCC(N)(CC(N)=O)CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HPGD P15428 1/20 0.40
EPHX2 P34913 1/20 0.40
OPRD1 P41143 1/20 0.39
OPRK1 P41145 1/20 0.39
GPR119 Q8TDV5 1/20 0.39
RECQL P46063 1/20 0.38
EPHX1 P07099 1/20 0.38
NAMPT P43490 1/20 0.38
MMP2 P08253 1/20 0.38
MMP13 P45452 1/20 0.38
MMP14 P50281 1/20 0.38
ADAM17 P78536 1/20 0.38
NR1H2 P55055 1/20 0.38
DDB1 Q16531 1/20 0.38
CRBN Q96SW2 1/20 0.38
TPSAB1 Q15661 1/20 0.37
TPSD1 Q9BZJ3 1/20 0.37
TPSG1 Q9NRR2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15268805 0.88 USP2 (0.46) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL5216557 0.85 USP2 (0.44) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL24442411 0.84 USP2 (0.46) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL1954007 0.84 USP2 (0.49) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL1586924 0.84 USP2 (0.49) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL605572 0.84 USP2 (0.49) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL21551293 0.84 SMN1; SMN2 (0.43) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL3187327 0.83 USP2 (0.47) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL8012970 0.83 USP2 (0.47) USP2SMN1; SMN2HPGDEPHX2OPRD1
SCHEMBL15657912 0.81 USP2 (0.46) USP2SMN1; SMN2HPGDEPHX2OPRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017156177-A1 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF RAZE THERAPEUTICS, INC. (US) 2017-09-14 WO disclosed